Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-25

FDA Approved: BRINZOLAMIDE — Supplemental Application (Oceanside Pharmaceuticals.)

View source ↗

Summary

The FDA approved a supplemental application for Brinzolamide submitted by Oceanside Pharmaceuticals. The approval concerns the generic drug Brinzolamide used to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brinzolamide (Brinzolamide)

Snippet

SUPPL AP for BRINZOLAMIDE (BRINZOLAMIDE)